Tools

LEADER 02471cam a2200493 a 4500

001 ssj0000525395;

003 WaSeSS;

005 20220112082112.0;

006 m d ;

007 cr n ;

008 110801s2011 dcua sb 000 0 eng d;

010 a| 2011283692;

020 a| 9780309212809 (pbk.);

020 a| 0309212804 (pbk.);

035 a| (WaSeSS)ssj0000525395;

040 a| SLUc| SLUd| DLCd| WaSeSS;

042 a| pcc;

043 a| n-us---;

049 a| EREEa| NEHH;

050 00 a| HD30.23b| .R573 2011;

245 02 a| A risk-characterization framework for decision-making at the Food and Drug Administrationh| [electronic resource] /c| Committee on Ranking FDA Product Categories Based on Health Consequences Phase II, Board on Environmental Studies and Toxicology, Division on Earth and Life Studies, National Research Council, Institute of Medicine.;

260 a| Washington, D.C. :b| National Academies Press,;

300 a| xiv, 192 p. :b| ill. ;c| 23 cm.;

500 a| "National Research Council of the National Academies.";

504 a| Includes bibliographical references.;

506 a| Available only to authorized users.;

538 a| Mode of access: World Wide Web;

610 10 a| United States.b| Food and Drug Administrationv| Case studies.=| ^A1253;

650 0 a| Decision makingz| United Statesv| Case studies.=| ^A991284;

650 0 a| Risk assessmentz| United Statesv| Case studies.=| ^A221641;

655 0 a| Electronic books.=| ^A491897;

710 2 a| National Academies (U.S.).b| Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II.=| ^A1333606;

710 2 a| National Research Council (U.S.)=| ^A416;

856 40 z| Full text available from Ebook Central - Academic Completeu| https://ebookcentral.proquest.com/lib/eastcarolina/detail.action?docID=3378782;

947 a| (OCoLC)ocn741786294;

949 a| CLICK ON WEB ADDRESSw| ASISh| JOYNER188;

949 a| CLICK ON WEB ADDRESSw| ASISh| HSL77;

949 a| CLICK ON WEB ADDRESSw| ASISh| JMUSIC60;

596 a| 1 3 4;

998 a| 4262355;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 4262355-1001l| JNETm| JOYNERr| Ys| Yt| JNESSBKu| 1/4/2016x| EBOOKz| JERESOURCE;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 4262355-2001l| HSLELECm| HSLr| Ys| Yt| HEBKu| 1/4/2016x| EBOOKz| HERESOURCE;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 4262355-3001l| MNETm| JMUSICr| Ys| Yt| MNESSBKu| 1/4/2016x| EBOOKz| JERESOURCE;

A risk-characterization framework for decision-making at the Food and Drug Administration / Committee on Ranking FDA Product Categories Based on Health Consequences Phase II, Board on Environmental Studies and Toxicology, Division on Earth and Life Studies, National Research Council, Institute of Medicine.

Other author	National Academies (U.S.). Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II.
Other author	National Research Council (U.S.)
Format	Electronic
Publication Info	Washington, D.C. : National Academies Press,
Description	xiv, 192 p. : ill. ; 23 cm.
Supplemental Content	Full text available from Ebook Central - Academic Complete
Subjects	United States. Food and Drug Administration--Case studies. Decision making--United States. --Case studies. Product safety--United States. --Decision making. --Case studies. Risk assessment--United States. --Case studies.

General note	"National Research Council of the National Academies."
Bibliography note	Includes bibliographical references.
Access restriction	Available only to authorized users.
Technical details	Mode of access: World Wide Web
Genre/form	Electronic books.
LCCN	2011283692
ISBN	9780309212809 (pbk.)
ISBN	0309212804 (pbk.)

Availability

Library	Location	Call Number	Status	Item Actions
	Electronic Resources	Access Content Online	✔ Available

Click here for more information about this title

Availability